Results 61 to 70 of about 5,707 (185)
Annals of Medicine, 1998 The objectives of the treatment of hyperprolactinaemia are to suppress excessive hormone secretion and its clinical consequences, to remove tumour mass, to preserve the residual pituitary function and to prevent disease recurrence or progression. Prior to the advent of pharmacotherapy, therapy usually consisted of surgical resection and/or pituitary ...
COLAO, ANNAMARIA +2 more
openaire +3 more sources
A Retrospective Study on the Impact of Primary Aldosteronism in Pregnancy (H.A.P.P.I. Study Group)
Clinical Endocrinology, Volume 104, Issue 2, Page 113-122, February 2026.ABSTRACT Objective Primary aldosteronism (PA) is a common cause of hypertension in young women. However, there is a paucity of data regarding its impact during pregnancy. The primary objective of this study was to describe the occurrence of hypertensive disorders of pregnancy (HDP) in PA.
Diana Oprea +7 more
wiley +1 more source
Stress‐Induced Activation of Prolactin‐NR4A1‐Midkine Axis Exacerbates Skin Inflammation
Advanced Science, Volume 13, Issue 5, 27 January 2026.Chronic psychological stress activates prolactin signaling to reprogram dermal fibroblasts into APCDD1+ inflammatory effectors via NR4A1, driving midkine secretion. This paracrine hub amplifies keratinocyte proliferation and immune recruitment, thus exacerbating skin inflammation.
Zhiguo Li +18 more
wiley +1 more source
Alzheimer's &Dementia: Translational Research &Clinical Interventions, Volume 12, Issue 1, January/March 2026.Abstract The etiology of Alzheimer's disease (AD) is incompletely understood. While it is widely accepted that amyloid beta (Aβ), the peptide making up the hallmark plaques of the disease, is involved in AD development, its precise role is not fully elucidated.
Jahnavi Shriram +3 more
wiley +1 more source
Successful treatment of a prolactinoma with the antipsychotic drug aripiprazole
Endocrinology, Diabetes & Metabolism Case Reports, 2016 In this report, we describe a female patient with both prolactinoma and psychotic disorder who was successfully treated with aripiprazole, a partial dopamine 2 receptor agonist.
Ilse C A Bakker +2 more
doaj +1 more source
MicroRNA networks in prolactinoma tumorigenesis: a scoping review
Cancer Cell InternationalBackground Prolactinoma is the leading type of pituitary adenoma. Aside from the mass-like effect of prolactinoma, its hormonal effect is the main pathological cause of endocrine dysregulation and infertility.
Sevil Ghaffarzadeh Rad +2 more
doaj +1 more source
Giant prolactinoma with progressive cranial settling and central herniation: a case report
Journal of Medical Case ReportsBackground Giant prolactinoma (size > 4 cm) is a rare condition and accounts for less than 1% of pituitary adenomas. In even rarer cases, these lesions may involve craniocervical structures requiring surgical intervention. The present case is the largest
Taha Shahbazi +3 more
doaj +1 more source
Long-term cardiac (valvulopathy) safety of cabergoline in prolactinoma
Indian Journal of Endocrinology and Metabolism, 2017 Background: Clinical relevance of association of cabergoline use for hyperprolactinemia and cardiac valvulopathy remains unclear. Objective: The aim of the study was to determine the prevalence of valvular heart abnormalities in patients taking ...
Shruti Khare +6 more
doaj +1 more source
Frontiers in EndocrinologyPurposeThe purpose of this study was to explore the factors influencing PRL levels in patients with prolactinoma and to investigate the correlations between anxiety, depression, sleep, self-efficacy, and PRL levels.MethodsThis retrospective study ...
Xiaoju Miao +14 more
doaj +1 more source